Weijing Sun
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 87
- Colorectal Cancer Treatments and Studies 35
- Cancer Immunotherapy and Biomarkers 16
- Pancreatic and Hepatic Oncology Research 16
- Colorectal Cancer Surgical Treatments 11
- Hepatology 16
- Hepatocellular Carcinoma Treatment and Prognosis 16
- Co-authors
- Peter James O'Dwyer (22 shared papers)Ursina R. Teitelbaum (5 shared papers)Daniel G. Haller (20 shared papers)Robert H. Vonderheide (3 shared papers)Elena Gabriela Chiorean (2 shared papers)Drew A. Torigian (2 shared papers)Gregory Lawrence Beatty (2 shared papers)Babak Saboury (2 shared papers)
- Journals
- Cancer (9 papers)Journal of Hematology & Oncology (7 papers)Clinical Colorectal Cancer (5 papers)Journal of Clinical Oncology (5 papers)Clinical Cancer Research (5 papers)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Weijing Sun
160 papers receiving 11.1k citations
Weijing Sun's Hit Papers
Peers
Comparison fields: 5 of 122
- Oncology 4.9k
- Hepatology 1.1k
- Immunology 1k
- Pulmonary and Respiratory Medicine 1.5k
- Cancer Research 544
Countries citing papers authored by Weijing Sun
This map shows the geographic impact of Weijing Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijing Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijing Sun more than expected).
Fields of papers citing papers by Weijing Sun
This network shows the impact of papers produced by Weijing Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijing Sun. The network helps show where Weijing Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Weijing Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 164 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer Hit paper breakdown → | 2018 | 1485 |
| 2 | CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans Hit paper breakdown → | 2011 | 1421 |
| 3 | Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial Hit paper breakdown → | 2018 | 1060 |
| 4 | Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma Hit paper breakdown → | 2019 | 590 |
| 5 | The Role of Angiogenesis in Hepatocellular Carcinoma Hit paper breakdown → | 2018 | 451 |
| 6 | 2013 | 395 | |
| 7 | 1994 | 305 | |
| 8 | 2005 | 293 | |
| 9 | Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial Hit paper breakdown → | 2018 | 293 |
| 10 | 2020 | 270 | |
| 11 | 2003 | 264 | |
| 12 | 2010 | 181 | |
| 13 | 2018 | 180 | |
| 14 | 2004 | 179 | |
| 15 | 2016 | 137 | |
| 16 | 2013 | 135 | |
| 17 | 2014 | 135 | |
| 18 | 2010 | 128 | |
| 19 | 2018 | 113 | |
| 20 | 2010 | 106 |
About Weijing Sun
Weijing Sun is a scholar working on Oncology, Hepatology, Pulmonary and Respiratory Medicine, Surgery and Cancer Research, having authored 164 papers that have together received 11.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (35 papers), Cancer Immunotherapy and Biomarkers (16 papers), Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Pancreatic and Hepatic Oncology Research (16 papers), Gastric Cancer Management and Outcomes (15 papers), Colorectal Cancer Surgical Treatments (11 papers), Esophageal Cancer Research and Treatment (9 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers). The work is most often cited by research in Oncology (4.9k citations), Hepatology (1.1k citations), Immunology (1k citations), Pulmonary and Respiratory Medicine (1.5k citations) and Cancer Research (544 citations). Weijing Sun has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Peter James O'Dwyer, Ursina R. Teitelbaum, Daniel G. Haller, Robert H. Vonderheide, Elena Gabriela Chiorean, Drew A. Torigian, Gregory Lawrence Beatty, Babak Saboury, Leslie L. Sharp and Wenru Song. Their work appears in journals such as Cancer, Journal of Hematology & Oncology, Clinical Colorectal Cancer, Journal of Clinical Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.